Tag: Pituitary tumor

Parlodel, the brand name for the medication bromocriptine, is a dopamine agonist with a long history of medical use, having been patented in 1968 and approved for various applications starting in 1975. This powerful medication is not used for a single purpose but rather addresses multiple medical conditions related to hormonal imbalances and neurological disorders.

According to research on pharmacovigilance databases, certain medications are disproportionately associated with reports of pituitary tumors, signaling a potential link, though not direct causation. The primary connection revolves around medication-induced hyperprolactinemia, a condition where drugs elevate prolactin levels and thereby increase the risk of developing a prolactin-secreting pituitary tumor, or prolactinoma.